Search Result "checkpoint kinase I (Chk1)"
Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 6 Year: 2008 Page: 577-597
Author(s): Helene Henon, Elisabeth Conchon, Bernadette Hugon, Samir Messaoudi, Roy M. Golsteyn, Michelle Prudhomme
Novel Checkpoint 1 Inhibitors
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 1 Year: 2006 Page: 55-68
Author(s): Michelle Prudhomme
Current Inhibitors of Checkpoint Kinase 2
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 4368-4374
Author(s): T. N.T. Nguyen, J. J. Tepe
Synthesis of Cis-Fused Pyran Indolocarbazole Derivatives that Inhibit FLT3 Kinase and the DNA Damage Kinase, Checkpoint Kinase 1
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2012 Page: 194-201
Author(s): Francoise M. Perron-Sierra, Nathalie Kucharkzyk, Celine Boucley, Christel Guyard-Daumas, Sophie Sciberras, Christine Fouache, Sabine Plantier, Aurelie Studeny, Celine Bossard, Patrick J. Casara, Roy M. Golsteyn
Theoretical Modelling of Potential Chk1 Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 12 Issue: 1 Year: 2015 Page: 60-65
Author(s): Pedro M.M. Araujo,Luis Pinto da Silva,Joaquim C.G. Esteves da Silva
Computer-Aided Drug Design of Pyranopyrazoles and Related Compounds for Checkpoint Kinase-1
Journal: Letters in Drug Design & Discovery
Volume: 6 Issue: 8 Year: 2009 Page: 579-584
Author(s): Rahul Ramtekkar, Kandhasamy Kumarvel, Gnanasambandam Vasuki, K. Sekar, R. Krishna
Enhancement of Chemotherapeutic Efficacy by Small Molecule Inhibition of NF-κ B and Checkpoint Kinases
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2007 Page: 1061-1074
Author(s): Vasudha Sharma, Christopher D. Hupp, Jetze J. Tepe
Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods
Journal: Current Computer-Aided Drug Design
Volume: 12 Issue: 4 Year: 2016 Page: 302-313
Author(s): Anand Balupuri, Pavithra K. Balasubramanian, Seung J. Cho
Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 186-191
Author(s): Suzanne Leijen, Jos H. Beijnen, Jan H.M. Schellens
Modulation of DNA Damage Checkpoint; Patenting and Possible Application for Cancer Medicine
Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 2 Issue: 1 Year: 2008 Page: 34-39
Author(s): Kazuhiro Ishikawa, Hideshi Ishii, Keiichi Ichimura